Newborn Screening Market

Market Synopsis:

The global Newborn Screening Market is valued at USD 3.44 Billion in 2024 and is projected to reach a value of USD 7.05 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.75% between 2025 and 2035.

Newborn Screening is a public health program run by various hospitals in which newborn babies are screened and identified with rare but serious medical conditions (genetic, hormonal, or metabolic conditions) that can interfere with average growth but are easy to treat. Newborn Screening includes a variety of tests, such as hearing tests, urine tests, and dry blood tests, that are performed during the first few hours or days of an infants life. These tests have the potential to help prevent a variety of health problems and deaths. From a simple urine and blood screening test to a more complex and comprehensive screening system capable of detecting many different conditions, Newborn Screening has developed. Newborn Screening tests detect various markers in an infants blood that can increase or decrease if the infant has certain diseases.

Congenital Hypothyroidism, Phenylketonuria (PKU), Cystic Fibrosis (CF), and other metabolic conditions can now be diagnosed using newborn screening tests that affect fat metabolism or protein metabolism. Additionally, the increased incidence of heart disease and genetic disorders among newborns is expected to fuel the Global Newborn Screening Market. Furthermore, governmental and private organizations' initiatives and advancements in new technologies are propelling the Global Newborn Screening Market forward. However, on the other hand, insufficient facts among parents about neonatal screening, a shortage of skilled professionals, and inaccuracy in some tests are significant factors that may impede the growth of the Global Newborn Screening Market.

Market Segmentation:

The Newborn Screening Market is segmented based on Product, Test, Technology, End User, and Region. Based on the segment Product, the market is further sub-segmented as Consumables Instruments, Hearing Screening Instruments, and Pulse Oximeters. Furthermore, based on the segment Tests, the market is sub-segmented into Dry Blood Spot Tests, Hearing Screening Tests, and CCHD Screening Tests. On the other hand, based on Technology, the market is sub-segmented as Immune Assays & Enzymatic Assays, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, and Other Technologies. Finally, the End-User segment is further categorized into sub-categories as Clinical Laboratories and Hospitals.

Based on Test:

Based on the segment Test, the Dried Blood Spot Tests (DBS) sub-segment is expected to maintain its dominance in the forecasted period. DBS sampling has been used for many years to screen newborn babies for congenital metabolic diseases. The benefits of DBS sampling include low volume requirements, Ease of occupying via finger or heel stick with minimal training, and Ease of transport and sample stability. In addition, this test can detect autism, lymphomas, leukemia, and other metabolic disorders. The advantage of Dried Blood Spot analysis is that it collects a small sample volume that can be easily moved. As a result, rising diseases in newborns are driving the market growth.

North America is projected to grow at the fastest CAGR during the forecast period

North America currently dominates the Newborn Screening Market and is expected to do so in the future. This is primarily due to the growing incidences of genetic diseases and mandatory testing in all 50 states of the U.S. The United States has observed the most extensive market growth in North America. This is primarily due to the growing incidence of newborn disorders and the increased demand for advanced systems. Every newborn in the United States is screened post-birth, with the analysis of diagnostic markers in blood spots collected on filter paper on the second day of an infants life. However, Newborn Screening programs are run state-by-state in the United States due to a lack of consistency among testing panels in many states. However, with the growing incidence of genetic disorders and the increasing number of childbirths, Asia Pacific is expected to experience significant growth in the Global Newborn Screening Market. The evolving healthcare infrastructure, technological advancements, and increasing awareness about Newborn Screening are expected to drive the Newborn Screening Market growth in Latin America, the Middle East, and Africa during the forecast period.

Competitive Landscape:

The key players in the Global Newborn Screening Market include- PerkinElmer (US), and others.

Segmentation of the Global Newborn Screening Market: